Comprehensive characterization of the cellular and molecular consequences of LCN2 loss in MDA-MB-231 triple-negative breast cancer cells
Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype characterized by high metastatic potential and limited targeted therapeutic options. Lipocalin-2 (LCN2) has been implicated in tumor progression and metastatic dissemination, but its functional role in TNBC remains incompletely understood....